0

540204

EIKO

img img img img
No Data Available

EIKO LIFESCIENCES LIMITED Share Price Update

As of the latest trading session, EIKO LIFESCIENCES LIMITED is trading at ₹50.51, up by ₹0.29 or 0.57% from its previous close. The stock has moved between ₹49.00 and ₹51.20 today. Over the past year, the stock has delivered a return of -1.32%. In the last month, it has returned 1.44%.

Investment Returns

Over 1 Month 1.44% Over 3 Months -6.38% Over 6 Months -4.21% Over 1 Year -1.32%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

EIKO LIFESCIENCES LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 72.40
  • P/E Ratio (TTM) 21.56
  • Beta 0.48
  • Book Value / share 42.77
  • Return on equity 2.75%
  • EPS (TTM) 2.16
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.95
info icon alternate text

EIKO LIFESCIENCES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 9.57
Operating Expense 8.88
Net Profit 0.95
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 0.69
EBITDA 1.43
Effective Tax Rate (%) 24.19
Particulars SEP 2025 (Values in Cr)
Revenue 9.20
Operating Expense 8.69
Net Profit 0.82
Net Profit Margin (%) 8.91
Earnings Per Share (EPS) 0.60
EBITDA 1.29
Effective Tax Rate (%) 23.36
Particulars JUN 2025 (Values in Cr)
Revenue 7.45
Operating Expense 7.10
Net Profit 0.69
Net Profit Margin (%) 9.26
Earnings Per Share (EPS) 0.50
EBITDA 1.08
Effective Tax Rate (%) 24.17
Particulars MAR 2025 (Values in Cr)
Revenue 7.09
Operating Expense 6.77
Net Profit 0.90
Net Profit Margin (%) 12.69
Earnings Per Share (EPS) 0.69
EBITDA 1.39
Effective Tax Rate (%) 24.16
Particulars DEC 2024 (Values in Cr)
Revenue 6.91
Operating Expense 6.63
Net Profit 0.28
Net Profit Margin (%) 4.05
Earnings Per Share (EPS) 0.24
EBITDA 0.55
Effective Tax Rate (%) 26.31
Particulars MAR 2025 (Values in Cr)
Revenue 32.49
Operating Expense 31.54
Net Profit 1.74
Net Profit Margin (%) 5.35
Earnings Per Share (EPS) 1.34
EBITDA 3.07
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 27.93
Operating Expense 27.12
Net Profit 0.75
Net Profit Margin (%) 2.68
Earnings Per Share (EPS) 0.73
EBITDA 1.78
Effective Tax Rate (%) 23.46
Particulars MAR 2023 (Values in Cr)
Revenue 18.32
Operating Expense 18.15
Net Profit 0.77
Net Profit Margin (%) 4.20
Earnings Per Share (EPS) 0.92
EBITDA 1.81
Effective Tax Rate (%) 25.24
Particulars MAR 2022 (Values in Cr)
Revenue 25.43
Operating Expense 25.14
Net Profit 0.71
Net Profit Margin (%) 2.79
Earnings Per Share (EPS) 0.90
EBITDA 1.96
Effective Tax Rate (%) 25.53
Particulars MAR 2021 (Values in Cr)
Revenue 11.99
Operating Expense 11.62
Net Profit 0.61
Net Profit Margin (%) 5.08
Earnings Per Share (EPS) 1.61
EBITDA 0.98
Effective Tax Rate (%) 26.50
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.26
ROE % 3.61
ROCE % 4.84
Total Debt to Total Equity 0.05
EBITDA Margin 9.60
Particulars MAR 2020 (Values in Cr)
Book Value / Share 7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.38
EBITDA Margin -43.27
Particulars MAR 2019 (Values in Cr)
Book Value / Share 12.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.30
EBITDA Margin -14.99
Particulars MAR 2018 (Values in Cr)
Book Value / Share 14.56
ROE % 3.60
ROCE % 4.66
Total Debt to Total Equity 0.31
EBITDA Margin 17.80
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.00
ROE % 2.75
ROCE % 3.84
Total Debt to Total Equity 0.02
EBITDA Margin 8.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 39.37
ROE % 1.87
ROCE % 2.82
Total Debt to Total Equity 0.00
EBITDA Margin 6.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 35.38
ROE % 2.65
ROCE % 3.79
Total Debt to Total Equity 0.08
EBITDA Margin 9.93
Particulars MAR 2022 (Values in Cr)
Book Value / Share 34.43
ROE % 3.45
ROCE % 6.01
Total Debt to Total Equity 0.16
EBITDA Margin 7.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.19
ROE % 6.77
ROCE % 9.15
Total Debt to Total Equity 0.12
EBITDA Margin 8.17
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 11.78
Total Assets 66.10
Total Liabilities 66.10
Total Equity 57.00
Share Outstanding 1
Price to Book Ratio 1.28
Return on Assets (%) 3.50
Return on Capital (%) 3.88
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 12.05
Total Liabilities 12.05
Total Equity 1.11
Share Outstanding 0
Price to Book Ratio 0.71
Return on Assets (%) -15.81
Return on Capital (%) -70.01
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 9.30
Total Liabilities 9.30
Total Equity 4.80
Share Outstanding 0
Price to Book Ratio 4.01
Return on Assets (%) -4.77
Return on Capital (%) -7.2
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 10.95
Total Liabilities 10.95
Total Equity 5.78
Share Outstanding 0
Price to Book Ratio 3.37
Return on Assets (%) 1.79
Return on Capital (%) 2.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 11.51
Total Assets 60.37
Total Liabilities 60.37
Total Equity 56.42
Share Outstanding 1
Price to Book Ratio 1.28
Return on Assets (%) 2.88
Return on Capital (%) 2.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.34
Total Assets 52.73
Total Liabilities 52.73
Total Equity 50.67
Share Outstanding 1
Price to Book Ratio 1.31
Return on Assets (%) 1.42
Return on Capital (%) 1.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 31.04
Total Liabilities 31.04
Total Equity 29.42
Share Outstanding 0
Price to Book Ratio 2.16
Return on Assets (%) 2.47
Return on Capital (%) 2.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 34.89
Total Liabilities 34.89
Total Equity 28.62
Share Outstanding 0
Price to Book Ratio 1.41
Return on Assets (%) 2.02
Return on Capital (%) 2.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.07
Total Assets 16.61
Total Liabilities 16.61
Total Equity 12.52
Share Outstanding 0
Price to Book Ratio 4.89
Return on Assets (%) 3.69
Return on Capital (%) 4.3
Particulars MAR 2025 (Values in Cr)
Net Income 3.06
Cash from Operations 3.23
Cash from Investing -11.44
Cash from Financing 6.95
Net change in Cash -1.56
Free Cash Flow 13.52
Particulars MAR 2020 (Values in Cr)
Net Income -4.93
Cash from Operations -0.30
Cash from Investing -0.70
Cash from Financing 0.94
Net change in Cash -0.08
Free Cash Flow -0.07
Particulars MAR 2019 (Values in Cr)
Net Income -0.99
Cash from Operations 0.18
Cash from Investing -0.29
Cash from Financing -0.55
Net change in Cash -0.68
Free Cash Flow 0.38
Particulars MAR 2025 (Values in Cr)
Net Income 2.31
Cash from Operations 2.33
Cash from Investing -9.85
Cash from Financing 5.97
Net change in Cash -1.83
Free Cash Flow 3.66
Particulars MAR 2024 (Values in Cr)
Net Income 0.98
Cash from Operations -7.04
Cash from Investing -0.54
Cash from Financing 20.36
Net change in Cash 12.73
Free Cash Flow -6.69
Particulars MAR 2023 (Values in Cr)
Net Income 1.02
Cash from Operations 4.14
Cash from Investing 0.87
Cash from Financing -4.70
Net change in Cash 0.39
Free Cash Flow 4.37
Particulars MAR 2022 (Values in Cr)
Net Income 0.94
Cash from Operations -7.51
Cash from Investing 0.59
Cash from Financing 3.28
Net change in Cash -3.85
Free Cash Flow -7.36
Particulars MAR 2021 (Values in Cr)
Net Income 0.83
Cash from Operations -0.64
Cash from Investing -2.93
Cash from Financing 7.81
Net change in Cash 4.05
Free Cash Flow -0.64
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ATUL LTD 6808.15 29.57 3.22 20044.39 5563.00 7793.00
BASF INDIA LTD 3640.10 43.20 4.15 15756.41 2906.90 5418.20
ORIENTAL AROMATICS LIMITED 307.70 0.00 1.56 1035.52 227.05 430.00
DEEPAK FERTILISERS & PETROCHEM 1263.45 18.23 2.44 15949.52 865.45 1776.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ADVANCE PETROCHEMICALS LTD. 230.70 419.45 5.58 20.76 97.60 230.70
ATUL LTD 6808.15 33.69 3.30 20044.39 5563.00 7793.00
BASF INDIA LTD 3640.10 40.79 4.13 15756.41 2906.90 5418.20
ORIENTAL AROMATICS LIMITED 307.70 42.68 1.50 1035.52 227.05 430.00

EIKO LIFESCIENCES LIMITED shareholding pattern

Holding
60.09%
39.9%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

EIKO LIFESCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
50.46 0.49 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 50.40
  • 26 Days 51.20
  • 10 Days 50.70
  • 50 Days 51.50
  • 12 Days 50.80
  • 100 Days 51.90
  • 20 Days 51.10
  • 200 Days 52.50
50.42 PIVOT
First Support 49.34 First Resistance 51.28 Second Support 48.48 Second Resistance 52.36 Third Support 47.40 Third Resistance 53.22
RSI 47.12 ADX 18.87 MACD -0.40 Williams % R -75.59 Commodity Channel Index (CCI) -110.44
Date 2026-04-30 Week 3981.00 Same Day 2313.00 Month 7890.00
1 Year 0.49 3 Year 0.44
Over 1 Month
1.44% down
Over 1 Year
-1.32% down
Over 3 Months
-6.38% down
Over 3 Years
-9.30% down
Over 6 Months
-4.21% down
Over 5 Years
-3.87% down

EIKO LIFESCIENCES LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares

Top Gainers

Top Losers

EIKO LIFESCIENCES LIMITED Share Price

Eiko Lifesciences Limited was originally incorporated on January 7, 1977, under the name Narendra Investments (Delhi) Limited. Later, Company was renamed from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited with effect from June 24, 2021. Earlier, Company engaged in sale and purchase of shares and securities. At present, Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally.

The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India. The key products manufactured by Company are used in pharmaceutical and agrochemical industries with various end use application including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others.

In 2022, Company completed the development of new molecules for Agrochemical Intermediates, Polymer Science and Pharma segment. Eiko developed these molecules and launched the same during FY22. The Company diversified into clinical research, development, and innovation within the specialty chemicals, healthcare and medical fields in 2025. It has entered into the container leasing and logistics sector through its subsidiary, EikoVivify Logistics Private Limited in FY 2025.

Parent organization Indian Private
NSE symbol [-]
Founded 1977
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Eiko Lifesciences Ltd?

Answer Field

Eiko Lifesciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 50.46 as on Apr 30 2026 03:28 PM.

What is the Market Cap of Eiko Lifesciences Ltd Share?

Answer Field

The market cap of Eiko Lifesciences Ltd for NSE ₹ 0.00 & for BSE ₹ 72.40 as on Apr 30 2026 03:28 PM.

What is the 52 Week High and Low of Eiko Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Eiko Lifesciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 65.90 and ₹ 45.90.

What is 1 year return for Eiko Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been -1.32%.

What is the P/E Ratio of Eiko Lifesciences Ltd Share?

Answer Field

As on Apr 30 2026 03:28 PM the price-to-earnings (PE) ratio for Eiko Lifesciences Ltd share is 21.56.

What is the PB ratio of Eiko Lifesciences Ltd Share?

Answer Field

As on Apr 30 2026 03:28 PM, the price-to-book (PB) ratio for Eiko Lifesciences Ltd share is 42.77.

How to Buy Eiko Lifesciences Ltd Share?

Answer Field

You can trade in Eiko Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Eiko Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Eiko Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Eiko Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|